Treats insomnia characterized. ANDA 77322, held by Sandoz. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 77322 (Zolpidem Tartrate), held by Sandoz, was first approved by FDA on Apr 23, 2007, with 11 approved supplements and 0 published complete response letters.
Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies. The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 23, 2007 | Original application | Approved |
| Zolpidem Tartrate5MG · tablet;oral | Zolpidem Tartrate | Rx |
| Zolpidem Tartrate10MG · tablet;oral | Zolpidem Tartrate | Rx |
| Sep 28, 2022 | Supplement 20Labeling · Standard review | Approved | None posted |
| Nov 19, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Nov 19, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Nov 19, 2019 | Supplement 17Labeling · Standard review | Approved | None posted |
| Nov 19, 2019 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 19, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Sep 4, 2013 | Supplement 12Labeling · Standard review | Approved | None posted |
| Nov 30, 2010 | Supplement 9Labeling | Approved | None posted |
| Mar 10, 2009 | Supplement 6Labeling | Approved | None posted |
| May 23, 2008 | Supplement 2Labeling | Approved | None posted |
| May 13, 2008 | Supplement 5Labeling | Approved | None posted |
| Apr 23, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters